Antibiotic Management of Lung Infections in Cystic Fibrosis. I. The Microbiome, Methicillin-Resistant <i>Staphylococcus aureus</i> , Gram-Negative Bacteria, and Multiple Infections
James F. Chmiel(Riley Hospital for Children), Félix Ratjen(Hospital for Sick Children), John J. LiPuma(University of Michigan), J.S. Elborn(Royal Brompton Hospital), Timothy R. Aksamit(Mayo Clinic), Sanjay H. Chotirmall(Nanyang Technological University), Elliott C. Dasenbrook(Cleveland Clinic), Sarath Ranganathan(Royal Children's Hospital), Valerie J. Waters(Hospital for Sick Children)
Cited by 198
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
|New England Journal of Medicine|2011|870
Consensus statement for inert gas washout measurement using multiple- and single- breath tests
|European Respiratory Journal|2013|797